Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Guidi

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Late-Onset Hepatic Veno-Occlusive Disease after Allografting: Report of Two Cases with Atypical Clinical Features Successfully Treated with DefibrotideAlessia Castellino, Stefano Guidi, Chiara Maria Dellacasa, et al.
Annals of Hematology|January 17, 2012
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO studyLuigi Rigacci, Bendetta Puccini, Anna Dodero, et al.
Blood Transfusion = Trasfusione Del Sangue|November 2, 2012
Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixaforGiuseppe Milone, Giovanni Tripepi, Massimo Martino, et al.
Blood|February 2, 2006
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulinMaria Teresa Van Lint, Giuseppe Milone, Salvatore Leotta, et al.
European Journal of Haematology|April 8, 2015
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative diseaseJosé Luis Piñana, Jaime Sanz, Albert Esquirol, et al.
Annals of Internal Medicine|November 17, 2010
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case reportSerena Guiducci, Francesco Porta, Riccardo Saccardi, et al.
European Journal of Haematology|March 3, 2007
Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myelomaBenedetto Bruno, Roberto Sorasio, Francesca Patriarca, et al.
Blood|March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availabilityBarbara Sarina, Luca Castagna, Lucia Farina, et al.
Haematologica|November 12, 2009
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO studyEmilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, et al.
American Journal of Hematology|April 23, 2013
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeEmilio Paolo Alessandrino, Matteo G Della Porta, Luca Malcovati, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Late-Onset Hepatic Veno-Occlusive Disease after Allografting: Report of Two Cases with Atypical Clinical Features Successfully Treated with DefibrotideAlessia Castellino, Stefano Guidi, Chiara Maria Dellacasa, et al.
Annals of Hematology|January 17, 2012
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO studyLuigi Rigacci, Bendetta Puccini, Anna Dodero, et al.
Blood Transfusion = Trasfusione Del Sangue|November 2, 2012
Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixaforGiuseppe Milone, Giovanni Tripepi, Massimo Martino, et al.
Blood|February 2, 2006
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulinMaria Teresa Van Lint, Giuseppe Milone, Salvatore Leotta, et al.
European Journal of Haematology|April 8, 2015
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative diseaseJosé Luis Piñana, Jaime Sanz, Albert Esquirol, et al.
Annals of Internal Medicine|November 17, 2010
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case reportSerena Guiducci, Francesco Porta, Riccardo Saccardi, et al.
European Journal of Haematology|March 3, 2007
Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myelomaBenedetto Bruno, Roberto Sorasio, Francesca Patriarca, et al.
Blood|March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availabilityBarbara Sarina, Luca Castagna, Lucia Farina, et al.
Haematologica|November 12, 2009
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO studyEmilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, et al.
American Journal of Hematology|April 23, 2013
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeEmilio Paolo Alessandrino, Matteo G Della Porta, Luca Malcovati, et al.
Pageof 5